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ORIGINAL ARTICLE
index (SSI), and by withdrawal reflex latency (WRL). In 
vitro  studies included cytocompatibility, flow cytometry, 
reverse transcriptase polymerase chain reaction and 
karyotype analysis of the MSCs. Histopathology of lung, 
liver, kidneys, and regional lymph nodes ensured the 
biomaterials biocompatibility. 
RESULTS: SSI remained negative throughout and 
independently from treatment. Differences between 
treted groups in the severity of changes in WRL existed, 
showing a faster regeneration for PVA-CNTs-MSCs (P  
< 0.05). At toe-off, less acute ankle joint angles were 
seen for PVA-CNTs-MSCs group (P  = 0.051) suggesting 
improved ankle muscles function during the push off 
phase of the gait cycle. In PVA-PPy and PVA-CNTs 
groups, there was a 25% and 42% increase of average 
fiber area and a 13% and 21% increase of the “minimal 
Feret’s diameter” respectively. Stereological analysis 
disclosed a significantly (P  < 0.05) increased myelin 
thickness (M), ratio myelin thickness/axon diameter (M/
d) and ratio axon diameter/fiber diameter (d/D; g-ratio) 
in PVA-CNT-MSCs group (P  < 0.05). 
CONCLUSION: Results revealed that treatment 
with MSCs and PVA-CNTs tube-guides induced better 
nerve fiber regeneration. Functional and kinematics 
analysis revealed positive synergistic effects brought by 
MSCs and PVA-CNTs. The PVA-CNTs and PVA-PPy are 
promising scaffolds with electric conductive properties, 
bio- and cytocompatible that might prevent the secondary 
neurogenic muscular atrophy by improving the reestab-
lishment of the neuro-muscular junction. 
Key words: Nerve regeneration; Neurotmesis; Tube-
guides; Mesenchymal stem cells; Carbon nanotubes; 
Functional assessment; Gait biomechanical analysis; 
Histomorfometry; Polyvinyl alcohol
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Core tip: The rat sciatic injury neurotmesis injury 
model is an appropriate model to evaluate the nerve 
regeneration when electric conductive tube-guides of 
polyvinyl alcohol (PVA)-carbon nanotubes (CNTs) and 
PVA-polypyrrole (PPy) associated to mesenchymal stem 
cells (MSCs) are used as scaffolds. The results obtained 
revealed that treatment with MSCs associated to PVA-
CNTs tube-guides induced an increased number of 
regenerated fibers and thickening of the myelin sheet. 
Functional and kinematics analysis revealed positive 
synergistic effects brought by MSCs and PVA-CNTs. The 
PVA-CNTs and PVA-PPy are promising scaffolds with 
electric conductive properties, bio- and cytocompatible 
that might prevent the secondary neurogenic muscular 
atrophy by improving the reestablishment of the neuro-
muscular junction.
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Abstract
AIM: To study the therapeutic effect of three tube-
guides with electrical conductivity associated to 
mesenchymal stem cells (MSCs) on neuro-muscular 
regeneration after neurotmesis.
METHODS: Rats with 10-mm gap nerve injury were 
tested using polyvinyl alcohol (PVA), PVA-carbon 
nanotubes (CNTs) and MSCs, and PVA-polypyrrole 
(PPy). The regenerated nerves and tibialis anterior 
muscles were processed for stereological studies after 
20 wk. The functional recovery was assessed serially for 
gait biomechanical analysis, by extensor postural thrust, 
sciatic functional index and static sciatic functional 
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INTRODUCTION 
Functional recovery is rarely satisfactory in patients 
where peripheral nerve repair is needed, remaining a 
challenging task in neurosurgery[1,2]. Direct repair is the 
procedure of choice but only when a tension-free end-
to-end suture is possible. However, for patients with 
loss of nerve tissue, resulting in a gap it is necessary to 
reconstruct the injured nerve using an autograft or a graft 
from a compatible donor[1,3]. One of the disadvantages 
of grafting is the necessity of a second surgery for 
collecting the nerve sample and respective donor site 
morbidity. In addition, non-matching donor and recipient 
nerve diameters often occur, which might be the reason 
for an incomplete functional recovery[4]. Entubulation 
offers advantages compared to graft implantation, 
including the potential to manipulate and to improve 
the regeneration environment within the tube-guide 
by adding to the lumen, growth factors and/or cellular 
systems[5]. Consequently, guidance of regenerating 
axons is improved by a mechanical effect but also by 
cellular growth factors, a chemical[6] and electrical cues[7]. 
Natural and synthetic biomaterials have been used as 
tube-guides, being the later sub-divided into two major 
groups: biodegradable and non-biodegradable[8,9]. The 
development of tube-guides is a consequence of the 
limitations inherent in the use of grafts, in terms of 
length, diameter and type of fiber, preventing damage to 
the sampling local, as it was previously referred[10]. For 
a correct nerve regeneration some important physical 
properties of tube-guides have been listed and referred 
by several authors like: the tube-guides should be made 
of biodegradable biomaterials with appropriate porous 
dimensions; the ability to deliver growth factors and 
drugs and allow the incorporation of cellular systems; an 
internal geometry to support an organized cell migration 
or intraluminal structures similar to nerve fascicles; 
and with some electrical activity in order to promote 
axon regeneration[11]. The use of electric conductive 
biomaterials to achieve nerve regeneration is a promising 
research area[12]. The goal of this work was to evaluate 
the therapeutic effect (by morphological and functional 
analysis) of three previously developed tube-guides with 
electrical conductivity for nerve regeneration associated 
to mesenchymal stem cells (MSCs) isolated from the 
Wharton’s jelly of umbilical cord (UC) on neuro-muscular 
regeneration after neurotmesis injury using the rat sciatic 
nerve model. The three tube-guides used in vivo where 
those made of polyvinyl alcohol (PVA), PVA loaded with 
MWCNTs [functionalized carbon nanotubes (CNTs), PVA-
CNTs], and PVA loaded with polypyrrole (PVA-PPy). Such 
composites with electric conductivity can be used to 
host cell therapies, and beneficial regenerative electrical 
stimulation can be applied directly to the cells through 
the composite[13]. PVA is a polymer used as a biomaterial 
due to its biocompatibility, non-toxic, non-carcinogenic, 
swelling properties, and bio-adhesive characteristics. 
PVA can also be used as host material in order to 
increase the solubility as well as the mechanical strength 
of conductive materials, and it is approved by Food and 
Drug Administration[14,15]. PPy and CNTs are two of the 
most studied conductive polymers for tissue engineering, 
especially for nerve tissue engineering[16]. The authors 
previously to in vivo application, focused on tube-
guides design and in vitro characterization. The PVA-
CNTs and PVA-PPy tube-guides presented conductivity 
advantages, important for nerve regeneration. The 
developed electrical conductive nerve tube-guides was 
achieved by loading PVA with 0.05% of PPy or COOH-
functionalized CNTs. The inclusion of CNTs and PPy 
brought a significant increase of electrical conductivity of 
the simple PVA tube-guide. The PVA-CNTs tube-guides 
showed the rougher topography. The DSC and X-ray 
diffraction (XRD) studies revealed that all materials have 
similar low crystallinity. The wettability studies indicated 
a hydrophilic behaviour of all nerve tube-guides, being 
the PVA-PPy slightly more hydrophobic. In terms of 
surface charge, the zeta potential measurements 
revealed that both COOH-functionalized CNTs and PPy 
loads turned the surface charge slightly more positive. 
Regarding the elastic behaviour, the COOH-functionalized 
CNTs load caused a slight decrease of the rigidity of PVA. 
PVA-CNTs and PVA-PPy might present a regenerative 
potential and were tested in the rat sciatic nerve 
neurotmesis injury model[17]. Also, since the PVA-CNTs 
presented the rougher topography, which is important 
for the association and viability of the associated cellular 
systems[9], where also tested associated to the MSCs-
based therapy[3,18].
Considering the peripheral nerve system (PNS), 
MSCs are promising cell-based therapies to be applied 
alone or associated to scaffolds. MSCs have a high 
plasticity, proliferative and differentiation capacity, 
and also have the advantage of presenting immuno-
suppressive properties[3,19,20]. For these reasons, MSCs 
have been used in experimental trials as cell-based 
therapies, including pathologies of PNS and central 
nervous system (CNS). Furthermore, nowadays the 
characterization of MSCs is well defined by recommen­
dations and standards stated by the international 
society for cellular therapy (ISCT)[19]. The MSCs 
therapeutic effect resides on their capacity to replace 
original cells of damaged tissues, and also by the 
physiologic secretion of growth factors and cytokines 
that modify the microenvironment inducing the activity of 
endogenous progenitor cells within the injured tissue, and 
by modulating the inflammatory and immune responses. 
The inflammatory modulation includes the Wallerian 
degeneration, a crucial step for nerve regeneration 
after neurotmesis injury[3]. Therefore, the use of cellular 
systems is a rational approach for promoting nerve 
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by MSCs are primarily responsible for their therapeutic 
action, so it is particularly important to understand and 
fully characterize the MSCs secretome[18,24,25]. Recent 
studies demonstrated that MSCs produce and secrete 
multiple paracrine factors like interleukine-2 (IL-2), 
IL-6, IL-8, IL-12, IL-15, monocyte chemoattractant 
protein-1, macrophage inflammatory protein-1β, 
regulated on activation, normal T cell expressed and 
secreted, and platelet-derived growth factor-AA. The 
several secreted factors previously listed that are 
present in MSCs conditioned medium (CM) was already 
described by others[26] and more recently, by our 
research group[18]. These paracrine factors are important 
to promote the MSCs therapeutic effects identified by 
the scientific community, like immunomodulatory and 
chemoattractive, anti­apoptotic, anti­fibrotic, angiogenic, 
and anti-oxidants activities. The hypothesis that MSCs 
and the growth factors produced during expansion in 
culture (CM) is an appropriate therapeutic product for 
local application in severe peripheral lesions seemed to 
be a rational approach and was studied in the present 
experimental work.
MATERIALS AND METHODS
Tube-guide preparation 
Synthetic biodegradable tubes of PVA (Aldrich, Mowiol 
10-98), PVA loaded with COOH-functionalized multiwall 
carbon nanotubes MWCNTs (Nanothinx, NTX5, MWCNTs 
97% - COOH) (PVA-CNTs tube-guides), and PVA loaded 
with PPy (Aldrich, 10-40 S/cm of conductivity) (PVA-PPy 
tube-guides) were prepared using a casting technique 
to a silicone mould. A 15% (%w/v) aqueous solution 
of PVA was prepared. Then the solution of PVA was 
mixed with 0.05% of COOH-functionalized MWCNTs 
and 0.05% of PPy. The tube-guides were produced by 
freezing/thawing process. The treatment consisted in 
three cycles of freezer (-30 ℃)/ incubator (25 ℃), and 
an annealing treatment started with a stage of 14 h on 
an incubator (25 ℃) followed by a ramp rate of 0.1 ℃
/min until 80 ℃, and then a stage of 20 h at 80 ℃. 
The tube-guides were sterilized by gama-radiation and 
hydrated in a sterile saline solution during 2 h before 
microsurgical application in the rat neurotmesis injuries 
(Figure 1).
MSCs cell culture and in vitro characterization
MSCs culture and expansion: Human MSCs isolated 
from the Wharton jelly (WJ) of UCT from PromoCell 
GmbH (C-12971, lot-number: 8082606.7) were cultured 
and expanded in a humidified atmosphere with 5% 
CO2 at 37 ℃ by replacing the mesenchymal stem cell 
medium, PromoCell (C-28010) every 48 h. At 80% 
confluence, normally obtained after 4 d in culture (Figure 
2), MSCs were harvested with 0.25% trypsin with EDTA 
(GIBCO) for further expansion at an initial concentration 
of 1 × 104 cells/cm2. Immediately previously to in vivo 
application, a MSCs suspension was prepared in 1 mL 
syringes. Each syringe contained MSCs at a concentration 
regeneration by delivering growth-promoting factors and 
cytokines at the nerve lesion site[9]. MSCs can be isolated 
from several tissues, including bone marrow (BM), 
umbilical cord blood (UCB) and umbilical cord tissue 
(UCT), dental pulp, and adipose tissue[9]. BM collection 
has several disadvantages, since the BM include a 
high percentage of adipocytes and a heterogeneous 
cell population, there is the possibility of morbidity 
associated to donor collection, as well as it is observed 
a decreasing number of BM-MSCs along the adult life 
and available for therapeutic applications. The research 
concerning other sources of MSCs has been intensively 
performed for the past years for identifying tissues that 
will allow MSCs isolation, and safe and controlled ex 
vivo expansion of these cells for potential allogeneic 
and autologous application[9]. MSCs isolated from the 
Wharton’s jelly UCT have been tested for the clinical 
application in CNS and PNS, including neurodegenerative 
diseases[21]. It has been reported that MSCs from the 
UCT are still viable 4 mo after transplantation and there 
is no need for immunological suppression of the patients 
and experimental animals[22]. The reason for this 
advantage is the fact that these cells are negative for 
major histocompatibility complex (MHC), and have low 
expression of MHC class Ⅰ[19] with potential application 
for MSC-based therapies in allogeneic treatments. 
In vivo studies involving these MSCs are limited but 
encouraging, especially what concerns PNS. Also, there 
are an increasing number of high quality cryopreserved 
cord tissue units in Cord Blood Banks worldwide. In 
addition, these cells represent a non-controversial source 
of MSCs, without neither ethical nor religious issues 
that are routinely harvested after birth, cryogenically 
stored, thawed, and can be expanded for therapeutic 
uses[9]. On the other hand, it was demonstrated in some 
studies, that grafted MSCs have a signalling role which 
initiates the recruitment and direction of endogenous 
cells by growth factors production, promoting the 
local regeneration and modulating the inflammatory 
process[23]. Nowadays it is believed that factors secreted 
Figure 1  Synthetic biodegradable tubes of polyvinyl alcohol, polyvinyl 
alcohol loaded with COOH-functionalized multiwall carbon nanotubes 
MWCNTs (polyvinyl alcohol-carbon nanotubes, polyvinyl alcohol-carbon 
nanotubes tube-guides), and polyvinyl alcohol loaded with polypyrrole 
(polyvinyl alcohol-polypyrrole, polyvinyl alcohol-polypyrrole tube-guides).
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of 1 × 106/μL for posterior intra-operatively nerve 
injection.
The MSCs lot used in the present experimental 
study was characterized by flow cytometry analysis 
for a comprehensive panel of markers by PromoCell 
as previously reported[18,25]. The MSCs exhibited a 
mesenchymal-like shape with a flat and polygonal 
morphology during cell culture expansion. Their pheno-
type was evaluated by flow cytometry for PE anti-
human cluster of differentiation-105 (CD105); APC anti-
human CD73; PE anti-human CD90; PerCP/Cy5.5 anti-
human CD45: FITC anti-human CD34; PerCP/Cy5.5 
anti-human CD14; Pacific Blue anti-human CD19 and 
pacific-blue anti-human Human Leukocyte Antigen-DR 
(HLA-DR) (antibodies and their respective isotypes from 
BioLegend).
MSCs karyotype by cytogenetic analysis: Cyto-
genetic analysis was carried out before in vivo application 
between passages 4 and 5 as previously reported[18,25]. 
Chromosome analysis was performed by one scorer on 
20 Giemsa-stained metaphases and each MSC cell was 
scored for chromosome number. For determination of the 
karyotype, a routine chromosome G-banding analysis 
was also carried out and no structural alterations were 
observed which demonstrates the chromosomal stability 
to the cell culture procedures and also that the in vivo 
applied MSCs are not neoplastic (Figure 2). 
Cytocompatibility evaluation of biomaterials: 
Intracellular free Ca2+ concentration ([Ca2+]i) by using 
dual wavelength spectrofluorometry as previously 
described[27] was measured in Fura-2-loaded MSCs cells. 
[Ca2+]i from MSCs cultured without the presence of 
any biomaterial, sub-cultured over PVA discs, over PVA 
loaded with CNTs (PVA-CNTs) and PVA loaded with PPy 
(PVA-PPy) discs of 10 mm diameter are results obtained 
from epifluorescence technique confirming that the 
MSCs did not begin the apoptosis process.
Reverse transcriptase polymerase chain reaction 
to confirm that MSCs are undifferentiated: Reverse 
transcriptase polymerase chain reaction (RT-PCR) 
and quantitative PCR (qPCR) targeting specific genes 
expressed by the MSCs that were in vivo applied was 
performed to certify that the MSCs used in vivo were not 
differentiated. For that, primers were designed targeting 
seven human genes based on the literature[18]. DNA 
sequences from growth associated protein-43 (GAP-43), 
neurofilament-H (NF-H), Nestin, Glyceraldehyde-3-
Phosphate Dehydrogenase (GAPDH), β-actin, neuronal 
nuclear (NeuN) and glial fibrillary acidic protein (GFAP) 
genes from mice (Mus musculus), rat (Rattus novergicus) 
and human (Homo sapiens) were downloaded from 
GenBank (www.ncbi.nlm.nih.gov/genbank) and aligned 
using the Clustal Omega bioinformatic tool from EMBL-
EBI (http://www.ebi.ac.uk/Tools/msa/clustalo). MSCs 
culture was harvested with 0.25% trypsin EDTA solution 
(Gibco) and centrifuged at 2000 rpm 4 ℃ during 5 min. 
Cell pellets were used for total RNA extraction using 
an adequate extraction kit, high pure RNA Isolation kit 
(Roche). Briefly, cell pellets were lysed with a lysis buffer, 
loaded into a High Pure Filter Tube, DNA was removed 
with DNase I enzyme, washed twice on column, and 
eluted with 100 μL of Elution Buffer. RNA was quantified 
and its quality assessed by using a Nanodrop ND-1000 
Spectrophotometer and reads from 220 nm to 350 
nm, and then stored at -80 ℃ until further use. In the 
following step, cDNA was synthesized from the purified 
RNA. To fulfill that issue, the kit Ready­To­Go You­Prime 
First-Strand Beads (GE Healthcare) was used following 
the manufacturer instructions. Briefly, 1.5 μg of total 
RNA was used and diluted in DEPC-treated water to a 30 
μL final volume in a RNase-free microcentrifuge tube; 
then heated at 65 ℃ for 10 min and then chilled in ice; 
transfer the RNA solution to the kit tube containing the 
first­strand reaction mix beads; add 0.2 μg of Oligo(dT) 
primer and DEPC-treated water to a 33 μL final volume; 
mix the content and incubate at 37 ℃ for 60 min. 
cDNA was synthesized and stored at -20 ℃ until further 
use. Of referring that, due to the use of the Oligo(dT) 
primer, the synthesized cDNA corresponds to the mRNA 
present in the sample at the time of collection. cDNA 
synthesized from undifferentiated MSCs was used to 
Figure 2  Mesenchymal stem cells culture and expansion. A: Isolated mesenchymal stem cells (MSCs) from the Wharton’s jelly of umbilical cord presented a 
fusiform, fibroblast-like morphology in culture (magnification: 100 ×); B: Selected metaphases from MSCs in culture, showing normal number of chromossomes (46, 
XY) (magnification: 1000 ×).
A B
400 μm
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check the expression of seven genes, two housekeeping 
genes (β-actin and GAPDH) and five specific of neuronal 
cells (GFAP, NeuN, Nestin, NF-H and GAP-43). Primers 
were designed in house and then synthesized in an 
external laboratory (MWG Operon, Germany). The 
primers were rehydrated in DNase/RNase free water in 
a concentration of 100 pmol/μL. qPCR was performed 
in a iCycler® iQ5TM (BioRad) apparatus using the iQTM 
SYBR® Green Supermix (BioRad). Each pair of primers 
targeting a gene was used to analyze its expression 
in the MSCs cDNA, in triplicate, along with a negative 
control. The plates containing the mix targeting the 
seven genes for both types of cells were submitted to 
the following cycles of temperatures: 95 ℃ during 4 min, 
35 cycles comprising 95 ℃ during 20 s, 55 ℃ during 20 s 
and 72 ℃ during 20 s ending with Real-Time acquisition, 
and final extension of 75 ℃ for 7 min. After cycling 
temperatures, the number of cycle threshold for each 
well was recorded. The plate containing the amplified 
genes or qPCR products was kept in ice and observed 
in a 2% agarose gel to check and reinforce the identity 
of the amplicons. Briefly, 2 g of NuSieve® 3:1 Agarose 
(Lonza) were mixed with 100 mL Tris-Acetate-EDTA 
buffer, melted, mixed with ethidium bromide in a final 
concentration of 0.2 μg/mL, and loaded in a horizontal 
electrophoresis apparatus. After solidification, 15 μL of 
the qPCR products were loaded in the agarose wells, 
and submitted to a 120 V potential difference during 40 
min to separate the amplicons. Gel was then observed 
under UV light and pictures recorded using the GelDoc® 
2000 (BioRad) and Quantity One® software (BioRad). In 
the MSCs, the molecular analysis showed a very small 
amplification of GFAP gene, absence of amplification 
of the NF-H and GAP-43 genes, and reasonable amp-
lification of NeuN, β-actin, GAPDH and Nestin genes. 
Amplification of a given gene is correlated with its 
expression seeing that the template DNA is the one 
generated from mRNA. The RT-PCR results confirmed 
that the MSCs used in vivo were not differentiated into 
neuro-glial cells.
Surgical procedure for the rat sciatic nerve model for 
neurotmesis
The article describes a basic research study involving 
animal subjects and was approved by the Veterinary 
Authorities of Portugal [Direcção Geral de Alimentação 
e Veterinária  (DGAV)] in accordance with the European 
Communities Council Directive of November 1986 
(86/609/EEC), and the National Institutes of Health (NIH) 
guidelines for the care and use of laboratory animals 
have been observed. Also all the authors involved in the 
in vivo tasks have a degree in Veterinary Medicine and 
are accredited by the Veterinary Authorities of Portugal 
(DGAV) and by Felasa - Category C for working with 
laboratory animals. 
The OECD Guidance Document on the Recognition, 
Assessment and Use of Clinical Signs as Humane 
Endpoints for Experimental Animals Used in Safety 
Evaluation (2000) were always followed by the authors 
by taking adequate measures to minimize pain and 
discomfort.
Polycarbonate cages type 3 were used for housing 
under standard laboratory conditions adult male 
Sasco Sprague Dawley rats with 300 g (Charles River 
Laboratories, Barcelona, Spain) always in a temperature 
and humidity controlled room with 12-12 h light/dark 
cycles. The rats were fed with standard chow and 
water ad libitum until the day of surgery. For surgery, 
the rats were anesthetized with ketamine 9 mg/100 g 
and xylazine 1.25 mg/100 g (body weight), by intra-
peritoneal administration. In lateral recumbence, the 
right sciatic nerve was exposed unilaterally and a 
transection injury was performed above the terminal 
nerve ramification using a straight microsurgical scissors, 
for creating a neurotmesis injury with 10 mm gap. 
Six experimental groups were studied: in groups 1, 2 
and 3 after neurotmesis the proximal and distal nerve 
stumps were inserted 3 mm into PVA (group 1: PVA), 
PVA loaded with 0.05% (%w/v) of COOH-functionalized 
MWCNTs (group 2: PVA-CNTs), and PVA loaded with 
PPy 0.05% (%w/v) tube­guides (group 3: PVA­PPY), 
respectively, and tube-guides were sutured with two 
epineural sutures using 7/0 polypropylene monofilament, 
maintaining a nerve gap of 10 mm; in group 4 after 
neurotmesis, an autologous 180° inverted graft was 
sutured between both nerve stumps (group 4: Graft); 
in group 5 after neurotmesis, immediate cooptation with 
7/0 monofilament polypropylene suture (group 5: End­
to-End); in group 6 after neurotmesis the proximal and 
distal nerve stumps were inserted 3 mm in a PVA loaded 
with 0.05% (%w/v) of COOH-functionalized MWCNTs 
tube-guide kept in place with 2 epineural sutures using 
7/0 monofilament polypropylene suture and the interior 
of the tube­guide was filled with 100 μm of MSCs at a 
concentration of 1 × 106 cells/μL in culture medium, also 
100 μm of MSCs at a concentration of 1 × 106 cells/μL 
in culture medium were infiltrated in both nerve stumps 
inserted in the tube-guide (group 6: PVA-CNTs-MSCs) 
(Figure 3). 
Functional assessment
After injury and sciatic nerve microsurgery reconstruction 
using the developed scaffolds in standardized neurot-
mesis injuries, a follow-up consisting in functional 
parameters measurements are important to evaluate 
the regeneration process and recovery. The animals 
were tested in an appropriate environment to minimize 
stress and handled by a single operator already trained 
for that purpose. Animals have been tested before the 
surgery at week 0, and after the surgery, at week 1, 
at week 2 and then every two weeks until the end of 
follow-up time of 20 wk. 
Evaluation of motor performance and nociceptive 
function: Motor performance was evaluated by measur-
ing extensor postural thrust (EPT) and nociceptive 
function using the withdrawal reflex latency (WRL). The 
EPT included in the neurological recovery evaluation 
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of the rat after sciatic nerve injury was first described 
by[28]. EPT is induced by lowering the affected hind-limb 
towards the platform of a digital balance supporting the 
animal by the thorax. During the test, the rat extends 
the hind-limb and the distal metatarsus and digits 
contact with digital platform balance. The force in grams 
(g) applied is recorded individually and the results for 
both hind-limbs (affected and un-affected hind-limb) are 
taken for equation 1 calculation. The normal (unaffected 
limb) EPT (NEPT) and experimental EPT (EEPT) values 
considered for equation (1) and the percentage of 
functional deficit is calculated[9,28-31]. 
    % Motor deficit = [(NEPT ­ EEPT)/NEPT] × 100     (1)
To assess the nociceptive WRL, the hotplate test 
described by Masters et al[32] was used with some 
modifications and previously described by the authors[3,9,
17,25,31,33]. Also, it is considered by the scientific biblio-
graphy that rats without sciatic nerve injury withdraw 
their paws from the hotplate within 4.3 s or less[9,17,31,33]. 
If there was no paw withdrawal after 12 s, the animal 
was assigned the maximal WRL of 12 s and the heat 
stimulus was removed to prevent tissue damage[34-36]. 
For sciatic functional index (SFI), a confined walkway 
measuring 42 cm long and 8.2 cm wide with a dark 
shelter at the end (own fabrication) that the rats cross 
was used. The footprints from the experimental (E) 
and normal (N) sides are measured: (1) distance from 
the heel to the third toe, the print length; (2) distance 
from the first to the fifth toe, the toe spread (TS); 
and (3) distance from the second to the fourth toe, 
Figure 3  Surgery of the rat sciatic nerve neurotmesis injury model. Under deep anesthesia the right sciatic nerve was exposed unilaterally through a skin incision 
extending from the greater trochanter to the mid-half distally followed by a muscle splitting incision (A). After nerve mobilization (B), a transection injury was performed 
(neurotmesis) using a straight microsurgical scissors (C). In group 5 (End-to-End) after neurotmesis, immediate cooptation with 7/0 monofilament polypropylene 
suture was performed (D). Implantation of the tube-guide in the 10 mm gap (E). Local application of the mesenchymal stem cells (MSCs), the MSCs suspension filled 
the polyvinyl alcohol (PVA)-carbon nanotubes (CNTs) tube-guide lumen (group 6: PVA-CNTs-MSCs) (F).
A B
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the intermediary toe spread (ITS). In the static sciatic 
functional index (SSI) is a simpler test where only the 
parameters TS and ITS are the measurements included 
in equation (6). Prints for measurements are chosen 
at the time of walking based on precise, clear and 
completeness of footprints[9,36,37]. The mean distances 
of 3 measurements are used to calculate the following 
factors (dynamic and static):
                        TSF = (ETS ­ NTS)/NTS                    (2)
                       ITSF = (EITS ­ NITS)/NITS                 (3)
                        PLF = (EPL ­ NPL)/NPL                       (4)
TSF: Toe spread factor; ITSF: Intermediate toe spread 
factor; PLF: Print length factor; ETS: Experimental toe 
spread; NTS: Normal toe spread; NITS: Normal inter-
mediary toe spread; EITS: Experimental Intermediary 
toe spread; NPL: Normal print length; EPL: Experimental 
print length.
SFI is calculated as described by Bain et al[38] 
according to the following equation:
SFI = ­38.3 × (EPL - NPL)/NPL + 109.5 × (ETS - 
NTS)/NTS + 13.3 × (EITS ­ NITS)/NITS ­ 8.8 = (­38.3 
× PLF) + (109.5 × TSF) + (13.3 × ITSF) - 8.8           (5)
Considering the SFI measurements, it was not 
possible to obtain values during the 20 wk follow-up 
after the surgery procedure, due to autotomy of the 
fingers. As a matter of fact, the rat sciatic nerve model 
for neurotmesis has this disadvantage; the autotomy 
observed in several experimental animals even when 
a repellant substance is applied routinely[9]. SSI was 
calculated as described by[39] according to the following 
equation (equation 6):
       SSI = 108.4 × TSF + 31.85 × ITF ­ 5.49       (6)
For SFI and SSI, when no footprints are measurable, 
the index score of -100 is given considering total 
impairment, on the other hand, a score of 0 means that 
there is no alteration and the footprint is normal. 
Kinematic analysis: Ankle kinematics was carried out 
at the end of the 20-wk follow-up time in the following 
experimental groups: PVA, PVA-CNTs, PVA-PPy, Graft, 
End-to-End, and PVA-CNTs-MSCs. A Perspex track with 
length, width (adjustable) and height of 120, 12, and 15 
cm, respectively was used to record the rat locomotion 
in a straight line. The animals’ gait was video recorded 
at a rate of 300 Hz images per second (Casio Exilim PRO 
EX­F1, Japan) by a camera with a visualization field of 
14 cm wide, that was positioned at the track half-length, 
and 1 m distant from the track, where gait velocity was 
steady. The software APAS® (Ariel Performance Analysis 
System, Ariel Dynamics, San Diego, United States) was 
used for data analysis. The authors used a two-segment 
model of the ankle joint, adopted from the model firstly 
developed by[40] (2D biomechanical analyses in sagittal 
plan), and the rat ankle angle was determined using the 
scalar product between a vector representing the foot 
and a vector representing the lower leg. Dorsiflexion and 
plantarflexion is considered for positive and negative 
values of position of the ankle joint (θ°). Initial contact 
(IC), opposite toe off (OT), and heel rise (HR) and toe-
off (TO)[33,40] were the time points analyzed for each 
step cycle, the values were time normalized for 100% 
of step cycle. The normalized temporal parameters were 
averaged over all recorded trials (Figure 4). Since the 
animal’s normal walking velocity is 20-60 cm/sA[33,40], 
stance phases lasting between 150 and 400 ms were 
considered for analysis.
Morphological analysis and histopathology: For 
histomorphometric analysis, nerve samples obtained 
from the 10-mm-long sciatic nerve segments distal to 
the neurotmesis site and from un-operated controls[41-44]. 
The histological nerve preparation followed the previously 
reported protocol[3,9,17,25,31,33,35] and a systematic random 
sampling and D-disector were adopted[41-44]. 
At the end of the healing period tested (week 20), 
tibialis anterior (TA) muscles of all experimental (PVA, 
PVA-CNTs, PVA-PPy, Graft, End-to-End, and PVA-CNTs-
MSCs) and Control (no lesion) groups were collected, 
and the tissue samples were fixed in 10% buffered 
formalin, routinely processed, dehydrated and embedded 
in paraffin wax. Consecutive 3 μm transverse sections 
from the mid-belly of each muscle were cut, stained with 
haematoxylin and eosin (HE) and used for morphometry 
evaluation and determination of the degree of atrophy. 
For the morphometric analysis, an unbiased sampling 
procedure was applied and the following measures were 
calculated: area, perimeter, “Feret’s angle” and “minimal 
Feret’s diameter” (which is the minimum distance of 
parallel tangents at opposing borders of the muscle 
fiber). These parameters were evaluated from the cross 
sections using the ImageJ© software (NIH) which allowed 
to apply this set of individual fiber measurements. A 
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minimum of 1000 skeletal muscle fibers was measured 
from each group. This assessment was performed by 
2 independent operators. Each one of the operators 
measured, blindly and randomly, an average of 50 fibers 
in each section. Images were acquired using a Nikon®
microscope connected to a Nikon® digital camera 
DXM1200, at low magnification (100 ×) under the same 
conditions that were used to acquire a reference ruler.
At the end of the study, all animals were subjected 
to a complete necropsy examination in order to evaluate 
the presence of possible internal anomalies and/or 
injuries. Lung, heart, kidneys, liver and spleen were 
collected and weighed and then submitted to histological 
analysis to check whether there were related microscopic 
changes such as inflammation, degeneration, or accumu­
lation of biological material. The organs were fixed 
in 10% buffered formalin and processed for routine 
histology with HE stain. Microscopically, massive carbon 
deposits generally appear as well-recognized anthracotic 
black pigment, especially in the lung. A recent report 
described that some types of carbon nanotubes may 
appear as small punctuated accumulations inside Kupfer 
cells (liver) and in the intermediate zone of the spleen, 
when intravenously administered[45]. Special stains, such 
as Von Kossa (method that demonstrates phosphates 
and carbonates) and Masson-Fontana (method used 
for distinguish carbon deposits from melanin) were also 
performed in consecutive sections.
Statistical analysis 
The statistical review of the study was performed by a 
biomedical statistician [PAS Armada-da-Silva, CIPER-
Faculdade de Motricidade Humana (FMH): Centro 
Interdisciplinar de Estudo de Performance Humana, FMH, 
Universidade de Lisboa, Estrada da Costa, 1499-002, 
Cruz Quebrada - Dafundo, Portugal]. 
A mixed model repeated measures ANOVA was 
used to test for differences across time and sciatic nerve 
treatment. Sphericity was assessed by Mauchly’s test 
and Greenhouse-Geisser degrees of freedom correction 
was used in cases sphericity could not be assumed or 
when corrected P-values were below the accepted level 
of significance (P < 0.05). Tukey’s HSD test was used 
for pairwise comparisons. All data is presented as mean 
and standard deviation, unless otherwise stated. These 
statistical tests were carried out with IBM SPSS Statistics 
version 19. For stereology, statistical comparisons of 
quantitative data were subjected to one-way ANOVA 
test, followed by pairwise comparisons using Tukey’s
HSD test. Statistical significance was established as 
P < 0.05. Stereological data was analyzed using the 
software using the SPSS version 19.0 (SPSS, Chicago, 
IL). For muscle morphometry, statistical analysis was
performed using the SPSS version 19.0 (SPSS, Chicago,
IL). Results are presented as mean ± scanning elec-
tron microscope (SEM) in Figures 5 and 6. Multiple 
comparisons between groups were performed by one-
way ANOVA supplemented with Tukey’s HSD post hoc 
test. Differences were considered statistically significant 
at P < 0.05.
RESULTS
Development and characterization of MSCs isolated 
from UC WJ
MSCs are defined by the ISCT which includes the 
following characteristics: (1) their capacity to adhere 
to plastic surfaces during cell culture; (2) expression of 
the specific surface markers (positive for CD73, CD90, 
and CD105, and no expression of CD14, CD19, CD34, 
CD45 and HLA-DR); and (3) are able to undergo tri-
lineage differentiation into adipocytes, chondrocytes 
and osteoblasts[19]. MSCs isolated from the UCT were 
expanded to P5-P6 where the culture appeared homo-
geneous and cells presented their typical fusiform, 
fibroblast­like, morphology (Figure 1). Flow cytometry 
analysis performed previously to in vivo application to 
expanded MSCs showed that over 95% of the cells in 
the population were consistently positive for the cell 
surface markers CD44, CD73, CD90 and CD105 and 
less than 2% positive for CD14, CD19, CD31, CD34, 
CD45 and HLA-DR. Also, the phenotype of MSCs was 
assessed by PromoCell by flow cytometry analysis for 
an additional comprehensive panel of markers: PECAM 
(CD31), HCAM (CD44), CD45, and Endoglin (CD105). 
Overall, these results are the ones expected for MSC-
type stem cells according to ISCT[19].
Giemsa-stained cells of MSCs at P5 were analyzed 
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for cytogenetic characterization. The karyotype of MSCs 
was determined previously to in vivo application to 
ensure that no neoplastic cells were used proving the 
cell therapy safety. The karyotype analysis demonstrated 
that no structural alterations were found, as well as 
chromosomal stability in terms of number and structure
of the somatic and sexual chromosomes, to the cell 
culture procedures. The transplanted MSCs also pre-
sented normal morphology and flow cytometry markers 
for MSCs according to ISCT[19].
Results obtained from epifluorescence technique 
confirmed that MSCs did not begin the apoptosis process, 
showing that the in vivo applied MSCs were viable even 
in the presence of the tube-guides biomaterials. The 
[Ca2+]i measured was 47.9 ± 4.5 (n = 25), 46.2 ± 3.5 
(n = 25) and 48.1 ± 3.9 (n = 25) for MSCs cultured 
in the presence of PVA, PVA-CNTs, and PVA-PPy discs 
after 7 d of culture, respectively. The MSCs cultured 
and expanded in the presence of the three tested 
biomaterials reached confluence and exhibited a normal 
star-like shape with a flat morphology in culture. 
According to these results, it is reasonable to conclude 
that the three biomaterials (PVA, PVA-CNTs, and PVA-
PPy) are viable substrate for MSCs culture and survival 
and may be used in the pre-clinical trials.
The MSCs were harvested and its RNA purified 
and converted to cDNA using adequate procedures. 
Primers targeting markers, two housekeeping genes 
(β-actin and GAPDH) and five specific of neuronal cells 
(GFAP, NeuN, Nestin, NF-H and GAP-43) were used 
to support the fact that the MSCs used in vivo were 
not differentiated into neuro-glial cells. The molecular 
analysis showed a very small amplification of GFAP 
gene, absence of amplification of the NF­H and GAP­43 
genes, and reasonable amplification of NeuN, β-actin, 
GAPDH and Nestin genes. Amplification of a given gene 
is correlated with its expression seeing that the template 
DNA is the one generated from mRNA. According to the 
results of RT-PCR, the molecular analysis showed a small 
expression of GFAP gene and absence of expression of 
the NF-H and GAP-43 genes in the expanded MSCs. 
Biomaterials characterization 
The electrical conductivity achieved for the different 
tube-guides (PVA, PVA-CNTs and PVA-PPy) was the 
following: 1.5 ± 0.5 × 10-6 S/m, 579 ± 0.6 × 10-6 S/m, 
and 1837.5 ± 0.7 × 10-6 S/m, respectively. Therefore 
these three tube-guide [simple PVA, PVA loaded with 
0.05% (%w/v) of COOH-functionalized CNTs and PPy] 
compositions were chosen for further characterization 
and for in vivo application in the rat sciatic nerve 
neurotmesis injury model. The thermal characteristics 
of simple PVA and loaded PVA materials was examined 
by differential scanning calorimetry and enthalpy of 
fusion (ΔH) was calculated, and the percentage of 
crystallinity was near 7.4% for all analyzed nerve 
guide tubes. Fourier transform infrared spectroscopy 
analysis the bands identified for PVA loaded with COOH­
functionalized CNTs were similar of the bands detected 
for simple PVA. For PVA loaded with PPy new bands 
appeared at 1313/cm (C - N stretching vibration in 
the ring) and 1170/cm (C - H in-plane deformation). 
Compared with simple PVA the other nerve guide tubes 
showed a less intensity of the peaks, especially between 
2237 and 2380/cm (unpublished data). Considering 
the XRD analysis previously performed, the broad peak 
observed at 20° corresponded to a typical diffraction 
peak of PVA, and it could be also observed in all tube-
guides. Near 26° a broad scattering peak appeared 
for the tube loaded with PPy, and it was an indication 
of the presence of PPy as supported in literature[46]; 
(unpublished data).
Both PVA and PVA loaded with PPy when analyzed 
by SEM exhibited similar surface appearance. On the 
other hand, the PVA loaded with COOH-functionalized 
CNTs showed a rougher surface as expected due to 
the presence of CNTs on PVA matrix, with oriented 
features. This characteristic was determinant to choose 
this biomaterial to be associated to the MSCs (PVA-
CNTs-MSCs group). The Wettability analysis showed 
a hydrophilic behavior for the three biomaterials used 
for tube-guide tested, also the three materials showed 
negative zeta potential being the PVA the most negative 
Figure 6  Macroscopic appearance of control tibialis anterior muscle and histological haematoxylin and eosin staining of a transverse section of tibialis 
anterior muscle. A: Macroscopic appearance of control tibialis anterior (TA) muscle (left) and 20 wk following neurotmesis and surgical treatment with PVA CNTs 
MSCs (right); B: Histological haematoxylin and eosin staining of a transverse section of TA muscle from PVA CNTs MSCs group. Magnification 40 ×. PVA: Polyvinyl 
alcohol; CNTs: Carbon nanotubes; MSCs: Mesenchymal stem cells.
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surface (-4.97 mV) (Figure 2).
Functional analysis during the healing period of 20 wk 
SFI and SSI analysis: A few SSI data were missing 
due to inability to collect visible fingerprints as it was 
previously referred. As a result of the limited number 
of animals and the limitations of repeated measures 
analysis, missing SSI values were replaced using 
interpolation. Nine of a total of 275 SSI values were 
interpolated with only one animal having two missing 
values replace using the linear interpolation procedure. 
Also because of missing values, the 2-wk time point 
was not considered for statistical analysis. Sciatic nerve 
neurotmesis caused a steep decrease in SSI scores in 
every experimental group and therefore a significant 
effect of time could be found [F(10, 200) = 20.445; 
P < 0.001]. SSI scores remained negative and with 
little changes throughout the time following sciatic 
nerve neurotmesis and independently from sciatic 
nerve treatment, leading to a non-significant time vs 
treatment interaction effect [F(40, 190) = 279.581; P 
< 0.651]. However, there was significant differences 
in the extent of SSI scores’ decrease between the 
experimental groups [F(4, 20) = 5.848; P < 0.01], 
with PVA-PPy tube-guides (P < 0.01) and PVA-CNTs-
MSCs (P < 0.01) groups showing less severe SSI scores 
compared with Graft group (Table 1). 
The motor performance by SFI was not possible 
to perform due to autotomy observed in all treated 
animals.
Evaluation of motor performance (EPT) and 
nociceptive function (WRL): In the weeks following 
sciatic nerve neurotmesis there was a large increase in 
the time latency to withdraw the paw in response to the 
thermal stimulus, with most animals reaching the cut-
off time of 12 s and leading to a significant effect of time 
[F(11, 341) = 17.944; P < 0.001]. A mild improvement 
in latency times occurred over the weeks of recovery 
at a rate that was similar between the experimental 
groups so that no significant interaction effect existed 
[F(55, 341) = 5.727; P < 0.503]. According to ANOVA 
results, differences between treated groups (PVA, PVA-
CNTs, PVA-PPy, PVA-CNTs-MSCs, Graft and End-to-
End) in the severity of changes in WRL times existed 
[F(5, 31) = 2.942; P < 0.05], but these differences 
were not large enough to be detected by the pairwise 
comparisons (Table 2). 
The motor performance by EPT was not possible 
to perform due to autotomy observed in all treated 
animals. 
Ankle joint kinematics: Measures of ankle joint angle 
at the four selected instants of the stance phase (IC, OT, 
HR and TO) were collected at the end of 20-wk recovery 
period. This analysis was carried out only for biomaterial 
(PVA, PVA-CNTs and PVA-PPy groups, n = 7) and 
biomaterial plus MSCs-treated animals (PVA-CNTs-MSCs 
group, n = 7). Ankle joint angle values were similar 
across the experimental groups at the times of IC, OT 
and HR (P = non­significant). However, at TO less acute 
ankle joint angles were seen for PVA-CNTs-MSCs group, 
compared with PVA-PPy group (P < 0.01) and with PVA-
CNTs group showing similar trend also compared with 
PVA-PPy group (P = 0.051). Such less acute ankle joint 
angles might suggest improved ankle muscles function 
during the push off phase of the rat’s gait cycle (Table 3 
and Figure 4). 
Morphological analysis 
Muscle results: After the healing period of 20 wk, TA 
muscle of all treated rats from the experimental groups 
(PVA, PVA-CNTs, PVA-PPy, PVA-CNTs-MSCs, Graft and 
End-to-End) was collect for histological analysis and 
morphometry to evaluate the secondary neurogenic 
muscle atrophy associated to neurotmesis injury. It was 
also evaluated the muscle healing process that followed 
the sciatic nerve regeneration where the scaffold 
Table 1  Static sciatic functional index
SSI Time
T0 T1 T2 T4 T6 T8 T10 T12 T14 T16 T18 T20
Group 1: PVA Mean  -3.13 -40.52 -52.76 -69.60 -60.30 -56.59 -63.51 -54.89 -40.25 -44.03 -57.34 -48.23
(n = 7) SD 24.17  19.25  17.78    9.56  19.69  13.19    8.05  11.96  13.33    9.07  21.81    7.25
Group 2: PVA-CNTs Mean 12.10 -41.85 -45.81 -68.07 -51.18 -52.22 -49.31 -44.52 -48.73 -37.65 -38.47 -38.99
(n = 7) SD 34.10  20.82  23.21  17.00  11.41  41.96  21.11  17.62  26.31  20.78  17.97  31.11
Group 3: PVA-PPy Mean   5.31 -41.40 -50.95 -45.76 -47.40 -34.56 -39.51 -31.52 -32.47 -43.17 -50.00 -36.08b
(n = 7) SD 17.51  17.52  23.99  29.92  22.53  14.00  25.05  15.10  20.78  25.52  11.77  16.09
Group 4: Graft Mean  -6.29 -56.46 -52.18 -55.41 -63.81 -59.79 -75.56 -53.15 -64.53 -67.22 -57.95 -52.07
(n = 4) SD   1.59  28.10  27.54  27.99  19.06  11.00  10.45  15.44  12.14  12.17    8.31    9.76
Group 5: End-to-End Mean  -5.78 -44.21 -33.72 -58.28 -73.92 -70.22 -52.47 -68.04 -41.91 -46.56 -43.04 -59.97
(n = 5) SD 12.91  15.34  15.72  22.25    6.82    6.44  27.43  11.02  24.55  16.79  12.31    2.64
Group 6: PVA-CNTs-MSCs Mean   3.46 -31.48 -23.75 -28.57 -39.97 -40.30 -62.32 -34.71 -26.28 -42.87 -37.54  -36.16b
(n = 7) SD 12.35  21.89  19.70    9.96    9.20  21.72  18.07  16.44  15.31  25.75  10.06  14.87
Static sciatic functional index (SSI) measured pre-operatively (week-0), and every week after the surgical procedure until week-20. An index score of 0 is 
considered normal and an index of 100 indicates total impairment. The measurements of the toe spread (TS), and the intermediary TS, were taken from the 
experimental (E) and normal (N) sides. Results are presented as mean and SD. n corresponds to the number of rats within the experimental group. PVA: 
Polyvinyl alcohol; CNTs: Carbon nanotubes; PPy: Polypyrrole; MSCs: Mesenchymal stem cells. bP < 0.01 vs Graft.
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still significantly different (P < 0.05) from the control 
group (without lesion) at 20 wk after lesion. PVA 
treatment without any coating (PVA group) revealed no 
regeneration benefit since the mean fiber size was lower 
(with significant difference in terms of “minimal Feret’s 
diameter”; P < 0.05) when compared to the Graft group 
(Figure 5). However, unexpected results were observed 
with PVA-CNTs-MSCs, which showed the worst results 
in terms of muscular atrophy after denervation, results 
not correlated with functional analysis (considering 
mostly kinematics gait analysis and SSI) (Figure 5). 
The decreased fiber size observed in these animals’ 
TA muscles was coincident with the smaller sized 
muscles that were collected at 20 wk after surgery 
macroscopically evaluated during the collection for 
histological evaluation. Histologically it was also possible 
to detect a considerable amount of necrosis with delayed 
muscle regeneration in this group’s muscles (Figure 6). 
Histomorphometry of the regenerated sciatic 
nerve: Histological analysis showed that nerve fiber 
regeneration occurred in all reconstructed nerves. In 
comparison to controls (sciatic nerve without neuro-
tmesis injuries, data not shown)[3], in all repaired 
nerves regenerated fibers showed small axons with 
thin myelin sheaths and microfasciculation (Figure 7). 
Microfasciculation was more evident in the PVA-CNTs-
MSCs repaired group (Figure 7 and Table 4). Also, 
stereological analysis disclosed a significantly (P < 0.05) 
larger axon diameter, but not fiber diameter, in the 
regenerated nerves from PVA-PPy group compared with 
those from PVA-CNT-MSC group (Table 4). On the other 
hand, as it was previously reported[3,25], the application 
of MSCs-based cell therapy to neurotmesis nerve 
injuries resulted in a significantly increased myelin 
thickness (M), ratio myelin thickness/axon diameter 
(M/d) and ratio axon diameter/fiber diamenter (d/D; 
g-ratio) when compared to PVA, PVA-CNTs, PVA-PPy 
groups (P < 0.05). The results clearly demonstrate a 
was applied. It was possible to observe by muscle 
morphometry that there was a significant difference 
(P < 0.05) in terms of the increase in mean fiber size 
between some of the treatment (PVA-PPy and PVA-
CNTs) groups and the Graft group. In fact, in the PVA-
PPy group there was a 25% increase in terms of average 
fiber area and a 13% increase in terms of the “minimal 
Feret’s diameter”, when compared to the Graft group. 
Whereas in the PVA-CNTs treatment group there was a 
42% increase in terms of average fiber area and a 21% 
increase in term of the “minimal Feret’s diameter”, when 
compared to the Graft group. Although both these two 
treatment groups (PVA-PPy and PVA-CNTs) exhibited 
significant improvement in fiber size, approaching the 
values for normal muscles (collected from rats with no 
sciatic nerve neurotmesis lesion), both of them were 
Table 2  Withdrawal reflex latency
WRL Time
T0 T1 T2 T4 T6 T8 T10 T12 T14 T16 T18 T20
Group 1: PVA Mean 3.71 10.95 10.81 10.68   9.74 10.23   9.85   8.15   7.78   9.99 7.88  6.98a
(n = 7) SD 0.93   1.45   2.04   2.26   2.89   2.50   2.81   2.70   3.50   2.49 3.72 3.72
Group 2: PVA-CNTs Mean 5.36   9.91   8.98   7.50   8.40   9.48   9.51   6.92   6.60   8.43 5.88  5.83a
(n = 7) SD 1.50   3.57   3.65   3.36   3.22   3.41   3.01   3.49   3.41   3.40 3.09 2.80
Group 3: PVA-PPy Mean 4.86 11.42   9.37   7.10   7.85   8.82   9.72   6.87   7.02   7.09 6.06  7.02a
(n = 7) SD 1.69   1.54   3.31   2.51   3.40   2.53   2.35   3.50   3.92   3.23 4.43 3.89
Group 4: Graft Mean 4.53 12.00 10.14 11.17 11.50 10.67 10.83 11.16   9.81 10.46 9.92  9.68a
(n = 4) SD 1.14   0.00   3.72   1.66   1.01   2.65   2.35   1.27   2.84   1.78 1.82 1.88
Group 5: End-to-End Mean 4.28 12.00 11.85 12.00 10.22 10.45   8.78 10.48   9.26   8.57 9.82 7.50
(n = 5) SD 0.86   0.00   0.34   0.00   2.50   2.12   2.22   2.86   3.07   0.98 2.02 0.87
Group 6: PVA-CNTs-MSCs Mean 3.93 12.00   8.89   9.23   9.30   9.90   7.65   7.41 10.06   8.33 8.28  8.02a
(n = 7) SD 0.86   0.00   2.36   1.63   2.72   2.66   2.51   2.33   1.85   2.86 2.34 1.20
Values in seconds were obtained performing withdrawal reflex latency (WRL) test to evaluate the nociceptive function. This test has been performed pre-
operatively (week-0), at week 1, week 2 and every 2 week after the surgical procedure until week-20, when the animals were sacrificed for morphological 
analysis. Results are presented as mean and standard error of the mean (SD). n corresponds to the number of animals within each experimental group. 
PVA: Polyvinyl alcohol; CNTs: Carbon nanotubes; PPy: Polypyrrole; MSCs: Mesenchymal stem cells. aP < 0.05 vs  End-to-End.
Table 3  Ankle kinematics
Temporal events Group Week 20
IC Group 1: PVA     -3.23 ± 20.65
Group 2: PVA-CNTs     -8.32 ± 17.36
Group 3: PVA + PPy      0.82 ± 26.33
Group 6: PVA-MSCs -13.68 ± 8.57
OT Group 1: PVA    28.30 ± 19.52
Group 2: PVA-CNTs    27.67 ± 12.91
Group 3: PVA + PPy    17.66 ± 13.20
Group 6: PVA-MSCs  11.43 ± 9.69
HR Group 1: PVA    46.67 ± 14.81
Group 2: PVA-CNTs    47.69 ± 11.19
Group 3: PVA + PPy    36.46 ± 10.14
Group 6: PVA-MSCs  34.07 ± 6.85
TO Group 1: PVA  33.99 ± 9.57
Group 2: PVA-CNTs    27.01 ± 10.99
Group 3: PVA + PPy  43.90 ± 8.76
Group 6: PVA-MSCs    20.56 ± 11.31
Values were obtained performing video analysis at 20-wk of the healing 
period. Results are presented as mean and standard deviation (SD) (n = 
7). For each step cycle the following time points were identified: Initial 
contact (IC), opposite toe off (OT), heel rise (HR) and toe-off (TO). PVA: 
Polyvinyl alcohol; CNTs: Carbon nanotubes; PPy: Polypyrrole.
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Table 4  Stereological quantitative assessment
Group Density Total Axon Fiber Myelin M/d D/d d/D Area 
number diameter (d) diameter (D) thickness (M) (g-ratio) (mm2)
Group 1: PVA Mean 42872 16596 2.95 3.56  0.31a  0.11a 1.23  0.82a 0.3862
(n = 7) SD   4007   1741 0.25 0.28 0.03 0.01 0.02 0.01 0.0772
Group 2: PVA-CNTs Mean 36261 16049 2.98 3.71  0.37a  0.14a 1.28  0.79a 0.4455
(n = 7) SD   4267   1172 0.25 0.27 0.01 0.01 0.03 0.01 0.1856
Group 3: PVA-PPy Mean 40289 22588  3.03a 3.70  0.33a  0.12a 1.24  0.81a 0.5720
(n = 7) SD   2686   3157 0.21 0.23 0.02 0.01 0.01 0.00 0.2565
Group 4: Graft Mean 37041 21939 2.58 3.56 0.49 0.21 1.41 0.71 0.5936
(n = 4) SD   1214   1302 0.06 0.08 0.02 0.01 0.02 0.01 0.0694
Group 5: End-to-end Mean 38762 22729 2.65 3.58 0.47 0.19 1.38 0.73 0.5990
(n = 5) SD   1524   2308 0.14 0.16 0.01 0.01 0.01 0.01 0.2082
Group 6: PVA-CNTs-MSCs Mean 43373 25731 2.44 3.34    0.45c,e    0.21c,e 1.41    0.72c,e 0.5942
(n = 7) SD   3881   3386 0.20 0.21 0.06 0.04 0.08 0.01 0.1940
Density, total number, axon diameter (d), fiber diameter (D), myelin thickness (M), ratio myelin thickness and axon diameter (M/d), ratio fiber diameter 
and axon diameter (D/d), ratio axon diameter and fiber diameter (d/D, g-ratio) of regenerated sciatic nerve fibers at week-20 after neurotmesis. Values are 
presented as mean ± SD. n corresponds to the number of animals within each experimental group. PVA: Polyvinyl alcohol; CNTs: Carbon nanotubes; PPy: 
Polypyrrole. aP < 0.05 vs PVA-CNT-MSC; cP > 0.05 vs End-to-End; eP > 0.05 vs Graft.
Figure 7  Histological appearance of regenerated nerve fiber in the different groups of neurotmesis. A: PVA; B: PVA-CNTs; C: PVA-PPy; D: PVA-CNTs-MSCs; E: 
Graft; F: End-to-end suture (magnification: 1000 ×). PVA: Polyvinyl alcohol; CNTs: Carbon nanotubes; PPy: Polypyrrole; MSCs: Mesenchymal stem cells.
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synergistic positive effect on regenerated nerve fibers 
resulting from combined use of MSCs with the PVA-CNTs 
tube-guides. Also, in the PVA-CNTs-MSCs group these 
three stereological parameters (M, M/d, and g-ratio) 
were not significantly different from the values obtained 
from End-to-End and Graft groups (Table 4). The total 
number of nerve fibers and nerve fibers density were 
similar in all groups.
Histology of internal organs: At the microscopic 
exam, no alterations were observed. The histology 
sections of all organs confirmed the absence of inflam­
mation, cell degeneration, necrosis and fibrosis. No signs 
of nanotubes, neither carbon deposits were detected in 
all organs.
DISCUSSION 
An organ re-innervation and functional recovery after 
nerve injury has been intensively studied worldwide 
and regenerative medicine methods including cellular 
systems and new biomaterials concerning the peripheral 
nerve have been developed. The involved mechanisms in 
the regeneration process and the ideal scaffold have not 
been discovered yet. Peripheral nerve might regenerate 
after some types of injury like axonotmesis but it is 
difficult to achieve functional recovery after neurotmesis, 
especially when there is loss of nerve tissue and a gap 
is created. In the peripheral nervous system, nerves 
after axonotmesis injuries can regenerate, without any 
treatment but in most clinical cases a muscle regional 
neurogenic atrophy occurs. When neurotmesis injuries 
occur, the nerves must be surgically treated by direct 
end-to-end suture[33,47,48], using appropriate micro-
surgery techniques and suturing material. Nowadays 
most tissue engineered nerve grafts are composed of a 
neural scaffold prepared with a variety of biomaterials, 
and surgically applied in neurotmesis injuries with loss 
of nervous tissue where the direct end-to-end suture 
is not possible creating tension in the suture line and 
compromising the nerve regeneration[9]. The introduction 
of cell therapies should be delivered by appropriate 
vehicles promoting an important biochemical and 
physical cue. MSCs represent an appealing source of 
adult stem cells for cell therapy and tissue engineering 
including peripheral nerve. Because MSCs are present 
in low percentage in the adult BM and also because of 
some of the disadvantages previously listed, alternative 
sources have been studied, like the UCT (also called 
Wharton’s jelly). MSCs were defined by the ISCT in 
2006, and since that time it is considered that MSCs 
must adhere to plastic; have a specific profile for the 
specific surface markers (positive for CD73, CD90, and 
CD105, and negative for CD14, CD19, CD34, CD45 
and HLA-DR). Other important characteristic is that 
MSCs are also able to undergo tri-lineage differentiation 
into adipocytes, chondrocytes and osteoblasts[19]. In 
vivo and in vitro studies referred that MSCs have the 
capacity to induce the regeneration of cartilage, bone, 
tendon, and meniscus[18]. The MSCs are also able to 
differentiate into neuro-glial cells, which have been 
studied in vitro and in vivo using animal models, by our 
research group[25]. Children and adult clinical trials have 
been performed where MSCs were used to treat a wide 
range of pathologies, including neurological disorders, 
PNS and CNS injuries (access www.clinicaltrials.gov). 
In fact, nowadays, the cryopreservation of UCB, and 
UCT is performed worldwide in private and public cord 
blood banks. Furthermore, the MSCs from the UCT and 
hematopoietic stem cells from the UCB have positive 
clinical outcomes not only in hematologic malignancy 
patients, where the MSCs work as a co-adjuvant for 
the hematopoietic transplant success, but also in PNS 
injuries and neurologic disorders. For that reason, the 
crucial role of MSCs in tissue renewal and regeneration 
has been well established for several limiting path-
ologies, not treated by the traditional therapeutic appro-
aches[49]. The in vivo application of MSCs performed by 
the authors was intended to improve the regeneration 
process in the rat sciatic nerve after a neurotmesis 
injury which was surgically reconstructed using electric 
conductive tube-guides of PVA-CNTs composition. At 
that moment there are several nerve tube-guides in 
the market, however they still have limitations and the 
functional outcome of the patients is still not complete. 
In this work the previously developed tube-guides 
with high electrical conductivity for nerve regeneration 
(unpublished data) were used in vivo using the rat 
sciatic nerve neurotmesis injury model. A matrix of PVA 
was used loaded with the following electrical conductive 
materials: COOH-functionalized multiwall carbon 
nanotubes (MWCNTs) and PPy PVA-CNTs and PVA-PPy 
tube, guides, respectively. The tubes production was 
carried out by a freezing/thawing process (physical 
cross-linking) and a final annealing treatment. After 
producing the tube-guides, the physicochemical chara-
cterization was performed. The most interesting results 
were achieved by loading PVA with 0.05% of PPy or 
COOH-functionalized CNTs, by combining the electrical 
conductivity of CNTs and PPy with the biocompatibility 
of PVA matrix, which seems to have potential to be 
used in peripheral nerve regeneration. For that reason, 
these two biomaterials were chosen to proceed for in 
vivo pre-clinical trials using the rat sciatic model. As a 
matter of fact, the microscopic exam performed to lung, 
heart, kidneys, liver and spleen collected after animal 
euthanasia, confirmed the absence of inflammation, 
cell degeneration, necrosis and fibrosis, and no signs 
of nanotubes, neither carbon deposits were detected 
in all organs, confirming the biocompatibility of these 
biomaterials loaded with CNTs. The evaluation of 
cytocompatibility was performed by measuring the [Ca2+]i 
in Fura-2-loaded MSCs cells by using dual wavelength 
spectrofluorometry, sub-cultured over PVA discs, over 
PVA loaded with carbon nanotubes (PVA-CNTs) and PVA 
loaded with PPy (PVA-PPy) discs of 10 mm diameter, as 
previously described[3,25,27]. Results correspond to [Ca2+]i 
from viable MSCs that did not begin the apoptosis 
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process, confirming the MSCs ability to expand and 
viability when associated to PVA, PVA-PPy and PVA-CNTs 
tube-guides. 
The MSCs isolated from the WJ used as cell-
based therapy for promoting nerve regeneration when 
associated to electric conductive tube-guides was 
previously in vitro validated concerning flow cytometry 
profile, RT-PCR, and cytogenetic analysis. MSCs 
were expanded to P5-P6 where the culture appeared 
homogeneous and cells presented their typical fusiform, 
fibroblast-like, morphology (Figure 1). Also, the flow 
cytometry analysis confirmed their profile according 
to ISCT[19] and the karyotype demonstrated that no 
structural alterations were present demonstrating 
absence of neoplastic characteristics in these cells, 
as well as chromosomal stability to the cell culture 
procedures. RT­PCR and qPCR targeting specific genes 
expressed by the MSCs in vivo applied was performed to 
certify that the MSCs used in vivo were not differentiated 
into neuro-glial cells. For the MSCs, the molecular 
analysis showed a very small amplification of GFAP gene, 
absence of amplification of the NF-H and GAP-43 genes, 
and reasonable amplification of NeuN, β-actin, GAPDH 
and Nestin genes, confirming that MSCs used in vivo 
were undifferentiated and not neuro-glial differentiated. 
In fact, the small detection of the GFAP gene expression 
may be due to the high sensitivity of the molecular 
tests in comparison with immunocytochemistry tests 
previously performed using undifferentiated and neuro-
glial type differentiated MSCs[3,18]. Moreover, the 
expression of the remaining genes, NeuN, β-actin, 
GAPDH and Nestin was also observed in undifferentiated 
MSCs. The expression of the housekeeping genes, 
β-actin and GAPDH, is expected to occur. As per the 
NeuN and Nestin gene, the observation of its expression 
in undifferentiated MSCs is not new; Bertani et al[50] 
showed that naïve MSCs express at a constitutive 
level NeuN gene, which increases when these cells are 
chemically induced to differentiate to pre-neuronal cells. 
Furthermore, compared gene expression profiles before 
and after MSCs induction for a number of germ layers, 
and observed that even before neuronal induction, 
MSCs population and clonal lines expressed a mixture 
of mesodermal, germinal, endodermal and ectodermal 
genes, including several whose expression was thought 
to be restricted to neuronal cells[51]. Molecular analysis 
previously performed[18] on these same genetic markers 
over the differentiated MSCs showed an increase in the 
expression of GFAP, NF-H and GAP-43 genes. These 
genes were not expressed, or expressed at very low 
levels, in the undifferentiated MSCs transcriptome. 
Overall, these results support the fact that the MSCs 
used in vivo were not differentiated but presented 
a neuro-glial potential for differentiation confirming 
previous results where the same MSCs undifferentiated 
and in vitro differentiated into neuro-glial cells were 
tested in axonotmesis and neurotmesis injuries associated 
to other biomaterials namely poly(DL-lactide-ε-caprolac-
tone), hybrid chitosan and collagen[3,25,31]. 
The rat sciatic nerve model has been widely used in 
experiments on peripheral nerve regeneration and it has 
been demonstrated that it is reliable and reproducible 
model, but research on peripheral nerve injury needs to 
include both functional and morphological analysis[52]. 
Since it is not generally agreed which type of evaluation 
tool is the most useful for evaluation of functional 
recovery; our research group like others has been using 
different methods for an overall assessment of nerve 
function, which has been widely recommended[53]. The 
sciatic nerve regeneration after neurotmesis studies 
described by the authors were followed during 20 wk 
after the surgical procedure based on the previous 
experimental work[17,29,54,55]. The morphological evaluation 
together with functional data has been used to assess 
neural regeneration after induced neurotmesis injuries, 
but some subjective evaluation, depending on the 
operator/research analysis is observed[9]. Some methods 
for evaluation of nerve recovery, like peroxidase and 
retrograde fluorescent labeling, histomorphometry, and 
retrograde transport of horseradish[47,56] fail in assessing 
the functional recovery, which is essential to evaluate 
the success of a scaffold application[57,58]. The present 
experimental work includes a variety of independent 
evaluation tools considering the morphologic and func-
tional recovery, in order to understand and estimate 
the potential therapeutic benefit of a nerve repair 
strategy[9]. EPT, WRL, SSI and SFI, have been proven 
to be valid methods and to give some information to 
determine functional recovery following sciatic nerve 
injury, including motor and nociceptive evaluation[59]. 
The use of biomechanical techniques and rat’s gait 
kinematic evaluation was a progress in documenting 
functional recovery, largely published by our research 
group[3,9,17,31,33,35]. Indeed, the use of biomechanical 
parameters allows an accurate analysis of the sciatic 
denervation/reinnervation process, permitting to 
understand the integration of the neural control acting on 
the ankle and foot muscles, and thus allowing to evaluate 
the nerve and muscle regeneration after neurogenic 
muscle atrophy associated to neurotmesis injuries[60,61]. 
At the end of the 20-wk healing period, it was performed 
kinematic gait analysis of rats from the groups where it 
was applied the biomaterial alone or associated to MSCs-
based therapies (PVA, PVA-CNTs, PVA-PPy, and PVA-
CNTs-MSCs groups) and measures of ankle joint angle 
at the four selected instants of the stance phase (IC, 
OT, HR and TO) were obtained (Table 3 and Figure 4). 
Considering the histological analysis, it was performed 
stereology of the regenerated sciatic nerves and 
morphometry analysis of the TA muscles, trying in this 
way, not only correlate the neurotmesis injury and the 
secondary neurogenic regional atrophy, but also consider 
and validate the morphometry of regional muscles 
(for instance, by biopsy of the injured muscle) as a 
method to assess functional recovery after peripheral 
nerve injuries[18,25]. The restoration of locomotor activity 
following damage of the PNS has emerged as one 
of the most important and critical clinical problem in 
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neuroscience and neurosurgery fields. Regional muscle 
weakness and impairment of joint control and mobility 
occurs in many patients with peripheral nerve or 
spinal cord injuries which results in gait disorders only 
evaluated with accuracy by kinematics analysis. During 
the past 10-15 years, experimental work has been 
carried out on rat gait analysis which may significantly 
contribute in the future for a more precise peripheral 
nerve research. Indeed, the use of biomechanical 
parameters permits an integration of the neural control 
acting on the ankle and foot muscles, relevant for the 
analysis of the sciatic denervation/reinnervation effects. 
The biomechanical analysis is very useful and accurate 
to evaluate different therapeutic approaches, describing 
high number of kinematic variables including positions, 
velocities, and accelerations, often using high speed 
digital cameras[35,40,62,63]. There is high variability between 
individual joint kinematics and between different animals 
from the same the same experimental group[64]. The high 
level of variability observed in normal quadruped walking, 
affects significantly the precision of joint kinematic 
measures of functional recovery after nerve injury. It is 
important to reduce this variability in kinematics analysis 
to assess functional recovery after neurogenic muscle 
atrophy and neurotmesis/axonotmesis injuries. One 
evident advantage is that using a treadmill the operator 
reduces step-by-step variability in joint kinematics[59] 
which has the disadvantage of being expensive equip-
ment. Also the possibility of combining kinematic 
analysis with other data, such as ground reaction forces, 
should be consider for a more accurate evaluation of 
nerve regeneration[59,64,65]. Our research group has 
recently analyzed hip, knee and ankle joint kinematics 
during recovery of rat sciatic nerve axonotmesis injury, 
using reflective markers attached to the rat hind-limb 
to track the motion with infra-red capture cameras, 
to better assess the rat sciatic nerve model hind-limb 
joint kinematics during walking. Due to physiological 
constraints and muscle actions it was observed that 
different joints have different motion patterns within 
motion planes, more evident when a 3D segmental 
kinematic analysis using a 3D reconstruction of the 
rat hind-limb was performed[9]. This method allowed a 
more complete segmental kinematic analysis using both 
planar angles computation (2D) and a 3D reconstruction 
of the rat hind-limb but unfortunately, in the present 
experimental work it was only possible to perform a 2D 
gait analysis[9]. In the present work, 2D biomechanical 
analysis (sagittal plan) was carried out applying a two-
segment model of the ankle joint, adopted from the 
model firstly developed by Varejão et al[40]. For that 
reason, ankle joint angle values were similar across the 
experimental groups at the times of IC, OT and HR. 
However, less acute ankle joint angles observed in PVA-
CNTs-MSCs group, compared with PVA-PPy and PVA-CNTs 
groups might suggest improved ankle muscles function 
during the push off phase of the rat’s gait cycle (Figure 4 
and Table 3). It is well known and demonstrated by the 
scientific bibliography that neuromuscular pathologies 
are related to important clinical signs or motor deficits 
that should be observed, qualified, and quantified, only 
possible with a precise kinematic analysis[65,66]. In the 
field of peripheral nerve research using the rat sciatic 
nerve model, an improved walking analysis might include 
several methods combination like joint kinematics, 
ground reaction forces and electromyographical data 
of muscle activity. These methods refinements might 
be important to differentiate the regenerative potential 
of different scaffolds used, that are not evident when 
using the traditional standardized methods previously 
referred[9,66].
The recent published paper by di Summa et al[67] 
where collagen tube-guides (Neurogen®) were used in 
vivo to promote peripheral nerve regeneration, combined 
with schwann cells (SCs), it was possible to demonstrate 
an improved distal stump sprouting[68]. This sprouting 
was more pronounced in the experimental group where 
the SCs were derived from BM-MSCs when compared 
to SCs derived from adipose tissue MSCs (AT-MSCs). On 
the other hand, no significant differences were observed 
in proximal regeneration among all the experimental 
groups. BM-MSCs and AT-MSCs -loaded conduits induced 
a diffuse sprouting pattern of the axons. On the other 
hand, the tube-guides loaded with SCs induced an 
enhanced cone pattern and a typical sprouting along 
the collagen type Ⅰ conduits walls, showing improved 
regenerating results. This observation is important 
and should be related to results obtained from the 
innervated muscle morphometry analysis. It should be 
bear in mind that the sprouting is also evaluated and a 
constant observation in the histomorphometry analysis 
of the regenerated peripheral nerve after axonotmesis 
and neurotmesis lesions, where different reconstruction 
strategies were tested in vivo in the rat model by our 
research group for the past years[3,25,31,68].
The morphometry and histological analysis of TA 
muscles collected from rats where the neurotmesis injury 
was reconstructed with PVA-CNTs-MSCs tube-guides 
is in fact somehow surprising since in the treatment 
groups presented in a previous published study (Gärtner 
et al[3], 2014), no adverse effect was noticed when MSCs 
isolated from UC WJ were used. The TA muscles from 
PVA-CNTs-MSCs group presented the worst results in 
terms of muscular atrophy after denervation, results 
not correlated with functional analysis (considering 
mostly kinematics gait analysis and SSI) (Figure 5). 
The decreased fiber size observed in these TA muscles 
was coincident with the smaller sized muscles that were 
collected at 20 wk, macroscopically evaluated during 
the collection for histological evaluation. Histologically 
it was also possible to detect a considerable amount 
of necrosis with delayed muscle regeneration in this 
group’s TA muscles (Figure 6). Some toxic metabolite 
resulting from the interaction between the vehicle where 
the MSCs are suspended (PBS) which has calcium and 
magnesium, and PVA-CNTs tube-guide, could explain 
the histological results. These results may occur, not 
because there is a deleterious effect of the cellular 
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system, but because the vehicle is not appropriate to the 
cells microenvironment. As a matter of fact these MSCs 
were previously tested associated to Floseal® and some 
local nerve necrosis could be observed by histological 
analysis. On the other hand, the myelin sheath of 
the MSCs-treated regenerated nerves was thicker, 
suggesting that MSCs might exert their positive effects 
on SCs, the key element in Wallerian degeneration 
and consequent axonal regeneration[3]. From the data 
obtained from the stereology analysis of PVA, PVA-CNTs, 
PVA-PPy, Graft, End-to-End and PVA-CNTs-MSCs groups, 
it was also demonstrated a synergistic positive effect on 
regenerated nerve fibers resulting from combined use 
of MSCs with the PVA-CNTs tube-guides, where PVA-
CNTs-MSCs presented higher myelin thickness (M), ratio 
myelin thickness/axon diameter (M/d) and ratio axon 
diameter/fiber diameter (d/D; g­ratio) when compared 
to PVA, PVA-CNTs, PVA-PPy groups (Table 4). Also, these 
three stereologic parameters (M, M7d, and g-ratio) 
measured in PVA-CNTs-MSCs regenerated nerves, were 
not significantly different from the values obtained from 
End-to-End and Graft groups. In conclusion, as it was 
previously reported[3,25], in the MSCs-based cell therapy 
applied to neurotmesis nerve injuries, it is observed 
a significantly higher myelin thickness, and similar to 
Graft and End-to-End regenerated nerves, which are 
considered the Gold Standards in nerve neurosurgery. 
These results clearly are consisted with functional data, 
from SSI and kinematic gait analysis. The PVA-CNTs 
and PVA­PPy groups presented significantly higher axon 
diameters (d) and fiber diameters (D), suggesting also 
the positive effect of these electric conductive materials 
on axon regeneration and reestablishment of the neuro-
muscular junction in agreement with the TA muscle 
morphometry analysis.
In conclusion, the results revealed that treatment 
with MSCs associated to PVA-CNTs tube-guides 
induced an increased number of regenerated fibers and 
thickening of the myelin sheet. Functional and kinematics 
analysis has revealed positive synergistic effects brought 
by MSCs and PVA-CNTs. The PVA-CNTs and PVA-PPy are 
promising scaffolds with electric conductive properties, 
bio and cytocompatible, that might prevent in some 
degree the secondary neurogenic muscular atrophy by 
improving the reestablishment of the neuro-muscular 
junction. Since the present studies were carried out in 
rats with human MSCs, it is important to continue these 
studies to evaluate the therapeutic potential of these 
MSCs in human nerve injuries. However, the results 
discussed herein show a promising effect of MSCs and 
PVA-CNTs tube-guides in in neurodegenerative diseases 
that are typified by demyelination since this scaffold 
induced myelin production in surgically reconstructed 
nerves after a neurotmesis injury. 
COMMENTS
Background
The sought for effective new therapeutic strategies for improving peripheral 
nerve regeneration represents one of the hot topics in biomedicine because 
of the high number of lesions affecting peripheral nerves (much higher than 
lesions to the spinal cord). 
Research frontiers
In this study, the authors have tested in vitro and in vivo mesenchymal stem 
cells (MSCs) derived from the umbilical cord matrix [Wharton’s jelly (WJ)] 
associated to electric conductive tube-guides developed by their research 
group, focusing on its effect in promoting nerve regeneration in the rat 
neurotmesis model. In particular, in vivo assessment of nerve regeneration 
and functional recovery was carried out using a comprehensive battery of 
complementary methods of analysis that the authors have developed along 
their previous experience in the study of nerve repair and regeneration and 
which include behavioral analysis of motor and nociceptive function, kinematic 
analysis using high speed cameras and histological analysis of nerve fiber 
regeneration. 
Innovations and breakthroughs
The results of this study open interesting perspectives for the clinical application 
of biodegradable membranes in peripheral nerve reconstruction associated to 
MSCs isolated from the umbilical cord matrix. Interestingly, these cells, which 
are major histocompatibility complex class Ⅱ negative, not only express both 
an immune-privileged and immune-modulatory phenotype, but their major 
histocompatibility complex class Ⅰ expression levels can also be manipulated, 
making them a potential cell source for MSC-based therapies. In addition, these 
cells represent a non controversial source of primitive mesenchymal progenitor 
cells that can be harvested after birth, cryogenically stored, thawed, and 
expanded for therapeutic uses. 
Applications
The results revealed that polyvinyl alcohol (PVA)-carbon nanotubes (CNTs) 
and PVA-polypyrrole (PPy) are promising scaffolds with electric conductive 
properties, bio and cytocompatible, that might prevent in some degree the 
secondary neurogenic muscular atrophy by improving the reestablishment 
of the neuro-muscular junction. Also, a promising effect of MSCs and PVA-
CNTs tube-guides in promoting myelin production in surgically reconstructed 
nerves after a neurotmesis injury was demonstrated. A new gateway it therefore 
opened for using these cells in neurodegenerative diseases that are typified by 
demyelination.
Terminology
Neurotmesis (in Greek tmesis signifies “to cut”) is part of Seddon’s classification 
used to classify nerve damage. It is the most serious nerve injury. In this type of 
injury, both the nerve and the nerve sheath are disrupted. Nowadays, when a 
nerve is damage and there is a neurotmesis injury with a gap, it can be repaired 
using a nerve tube-guide, whenever it is not possible to perform an end-to-
end suture without tension or there isn’t a graft available. This work focused 
on the development of electrical conductive nerve tube-guides, which was 
achieved by loading PVA with PPy or COOH-functionalized CNTs and their in 
vivo application in the rat sciatic nerve neurotmesis injury model. The inclusion 
of CNTs and PPy brought a significant increase of electrical conductivity of 
the simple PVA tube-guide. MSCs as defined by the international society for 
cellular therapy in 2006, are cells characterized by: (1) their capacity to adhere 
to plastic; and (2) expression of specific surface markers, namely, CD73, CD90, 
and CD105, and no expression of CD14, CD19, CD34, CD45 and human 
leukocyte antigen-DR. Additionally, MSCs are able to undergo tri-lineage 
differentiation into adipocytes, chondrocytes and osteoblasts. 
Peer-review
The article is very interesting. The experimental part is very well designed.
REFERENCES 
1 Lundborg G. Enhancing posttraumatic nerve regeneration. J 
Peripher Nerv Syst 2002; 7: 139-140 [PMID: 12365560 DOI: 
10.1046/j.1529-8027.2002.02019.x]
2 Ribeiro J, Gartner A, Pereira T, Gomes R, Lopes MA, Gonçalves 
 COMMENTS
Ribeiro J et al . Neuro-muscular regeneration in neurotmesis injury
973 July 26, 2015|Volume 7|Issue 6|WJSC|www.wjgnet.com
C, Varejão A, Luís AL, Maurício AC. Perspectives of employing 
mesenchymal stem cells from the Wharton’s jelly of the umbilical 
cord for peripheral nerve repair. Int Rev Neurobiol 2013; 108: 
79-120 [PMID: 24083432 DOI: 10.1016/B978-0-12-410499-0.000
04-6]
3 Gärtner A, Pereira T, Armada-da-Silva P, Amado S, Veloso A, 
Amorim I, Ribeiro J, Santos J, Bárcia R, Cruz P, Cruz H, Luís A, 
Santos J, Geuna S, Maurício A. Effects of umbilical cord tissue 
mesenchymal stem cells (UCX®) on rat sciatic nerve regeneration 
after neurotmesis injuries. J Stem Cells Regen Med 2014; 10: 14-26 
[PMID: 25075157]
4 May M. Trauma to the facial nerve. Otolaryngol Clin North Am 
1983; 16: 661-670 [PMID: 6634187]
5 Fields RD, Le Beau JM, Longo FM, Ellisman MH. Nerve 
regeneration through artificial tubular implants. Prog Neurobiol 
1989; 33: 87-134 [PMID: 2678271 DOI: 10.1016/0301-0082(89)9
0036-1]
6 Meek MF, Coert JH. Clinical use of nerve conduits in peripheral-
nerve repair: review of the literature. J Reconstr Microsurg 2002; 
18: 97-109 [PMID: 11823940 DOI: 10.1055/s-2002-19889]
7 Ghasemi-Mobarakeh L, Prabhakaran MP, Morshed M, Nasr-
Esfahani MH, Baharvand H, Kiani S, Al-Deyab SS, Ramakrishna 
S. Application of conductive polymers, scaffolds and electrical 
stimulation for nerve tissue engineering. J Tissue Eng Regen Med 
2011; 5: e17-e35 [PMID: 21413155 DOI: 10.1002/term.383]
8 Jiang X, Lim SH, Mao HQ, Chew SY. Current applications and 
future perspectives of artificial nerve conduits. Exp Neurol 2010; 223: 
86-101 [PMID: 19769967 DOI: 10.1016/j.expneurol.2009.09.009]
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59 Gärtner A, Pereira T, Gomes R, Luis AL, França ML, Geuna S, 
Armada-da-Silva P, Mauricio AC. Mesenchymal Stem Cells from 
Extra-Embryonic Tissues for Tissue Engineering-Regeneration of 
the Peripheral Nerve. 2013 [DOI: 10.5772/53336]
60 Varejão AS, Cabrita AM, Geuna S, Melo-Pinto P, Filipe VM, 
Gramsbergen A, Meek MF. Toe out angle: a functional index 
for the evaluation of sciatic nerve recovery in the rat model. Exp 
Neurol 2003; 183: 695-699 [PMID: 14552911]
61 Varejão AS, Cabrita AM, Meek MF, Bulas-Cruz J, Gabriel RC, 
Filipe VM, Melo-Pinto P, Winter DA. Motion of the foot and ankle 
during the stance phase in rats. Muscle Nerve 2002; 26: 630-635 
[PMID: 12402284 DOI: 10.1002/mus.10242]
62 Varejão AS, Cabrita AM, Meek MF, Fornaro M, Geuna S, 
Giacobini-Robecchi MG. Morphology of nerve fiber regeneration 
along a biodegradable poly (DLLA-epsilon-CL) nerve guide filled 
with fresh skeletal muscle. Microsurgery 2003; 23: 338-345 [PMID: 
12942524 DOI: 10.1002/micr.10147]
63 Costa LM, Simões MJ, Maurício AC, Varejão AS. Chapter 7: 
Methods and protocols in peripheral nerve regeneration experi-
Ribeiro J et al . Neuro-muscular regeneration in neurotmesis injury
975 July 26, 2015|Volume 7|Issue 6|WJSC|www.wjgnet.com
mental research: part IV-kinematic gait analysis to quantify 
peripheral nerve regeneration in the rat. Int Rev Neurobiol 2009; 87: 
127-139 [PMID: 19682636 DOI: 10.1016/S0074-7742(09)87007-4]
64 Jacobson S, Guth L. An electrophysiological study of the early 
stages of peripheral nerve regeneration. Exp Neurol 1965; 11: 
48-60 [PMID: 14272559 DOI: 10.1016/0014-4886(65)90022-1]
65 Pereira T, Gärtner A, Amorim I, Armada-da-Silva P, Gomes R, 
Pereira C, França ML, Morais DM, Rodrigues MA, Lopes MA, 
Santos JD, Luis AL, Maurício AC. Biomaterials and Stem Cell 
Therapies for Injuries Associated to Skeletal Muscular Tissues. 
2013 [DOI: 10.5772/5335]
66 Harley BA, Hastings AZ, Yannas IV, Sannino A. Fabricating 
tubular scaffolds with a radial pore size gradient by a spinning 
technique. Biomaterials 2006; 27: 866-874 [PMID: 16118016 
DOI: 10.1016/j.biomaterials.2005.07.012]
67 di Summa PG, Kingham PJ, Campisi CC, Raffoul W, Kalber-
matten DF. Collagen (NeuraGen®) nerve conduits and stem cells 
for peripheral nerve gap repair. Neurosci Lett 2014; 572: 26-31 
[PMID: 24792394 DOI: 10.1016/j.neulet.2014.04.029]
68 Gärtner A, Pereira T, Simões MJ, Armada-da-Silva PA, França 
ML, Sousa R, Bompasso S, Raimondo S, Shirosaki Y, Nakamura Y, 
Hayakawa S, Osakah A, Porto B, Luís AL, Varejão AS, Maurício 
AC. Use of hybrid chitosan membranes and human mesenchymal 
stem cells from the Wharton jelly of umbilical cord for promoting 
nerve regeneration in an axonotmesis rat model. Neural Regen Res 
2012; 7: 2247-2258 [PMID: 25538746]
P- Reviewer: Aramwit P, Romani A    S- Editor: Ji FF 
L- Editor: A    E- Editor: Liu SQ 
Ribeiro J et al . Neuro-muscular regeneration in neurotmesis injury
                                      © 2015 Baishideng Publishing Group Inc. All rights reserved.
Published by Baishideng Publishing Group Inc
8226 Regency Drive, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgoffice@wjgnet.com
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
http://www.wjgnet.com
